Konyang University Hospital has partnered with Japan's National Institutes for Quantum Science and Technology (QST) to study ...

Four risk factors increase the risk of developing stomach cancer, one of the most common cancers in Korea. These are ...

Neurophet, a Korean brain imaging software firm, is making a high-stakes bet on Alzheimer’s, and it’s counting on Eli Lilly ...

Yuhan Corp. is exploring various collaborative strategies to develop new obesity drugs. In addition to securing the ...

Korea's Lotte Biologics is stacking up its antibody-drug conjugate (ADC) partnerships, this time tapping AbTis, Dong-A ST’s ...

Huons Group held a ceremony Friday at its headquarters in Pangyo, Seongnam, Gyeonggi Province, to commemorate the company’s ...

Yuhan Corp. is wrapping up its chemo-free phase 2 lung cancer trial just as Johnson & Johnson pushes for reimbursement of ...

Rhythm Pharmaceuticals, a U.S. company that bought a global license from LG Chem for its oral orphan obesity drug Bivamelagon ...

Astellas Korea will reapply for health insurance coverage for its new drug Vyloy (zolbetuximab), a targeted treatment for ...

A medical society has recommended expanding national mandatory vaccinations for major infectious diseases that threaten the ...

Visiting and managing patients with major depressive disorder who have attempted suicide, instead of waiting for them to come ...

Citrelin (taltirelin), a treatment for spinocerebellar degeneration (SCD), a neurological disease, has crossed the threshold ...